Varizig approved to reduce chickenpox symptoms
(HealthDay)—Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus ...
Medications
Dec 22, 2012 |
not rated yet |
0
First human tests of meth medication completed
(Medical Xpress)—InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight ...
Medications
Dec 20, 2012 |
not rated yet |
0
|
FDA approves new drug for inhaled anthrax
Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax.
Medications
Dec 14, 2012 |
not rated yet |
0
Vitamin D can help infection-prone patients avoid respiratory tract infection
Treating infection-prone patients over a 12-month period with high doses of vitamin D reduces their risk of developing respiratory tract infection – and consequently their antibiotic requirement. This according to a new ...
Health
Dec 13, 2012 |
5 / 5 (1) |
0
Ebola virus uses a protein decoy to subvert the host immune response
In a study published today in the Open Access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its ...
Immunology
Dec 13, 2012 |
5 / 5 (1) |
0
|
Immunogenicity strongly impacts response to adalimumab in RA
(HealthDay)—For patients with rheumatoid arthritis (RA), long-term clinical outcomes are good with etanercept and adalimumab; but for adalimumab, treatment response is strongly dependent on the presence ...
Arthritis & Rheumatism
Dec 13, 2012 |
not rated yet |
0
New discovery makes early diagnosis of Sjogren's syndrome a reality for the first time
(Medical Xpress)—Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University ...
Immunology
Dec 13, 2012 |
not rated yet |
0
|
Targeted micro-bubbles detect artery inflammation, study finds
(Medical Xpress)—Heart disease is a leading cause of death throughout the world. Doctors say that it is important to detect heart disease early before it becomes too serious. Now, researchers at the University of Missouri ...
Cardiology
Dec 12, 2012 |
2 / 5 (1) |
0
|
New research helps predict susceptibility to Burkitt lymphoma
New research, presented this morning at the 54th Annual Meeting of the American Society of Hematology (ASH), has identified important associations between Plasmodium falciparum (Pf) malaria and endemic Burkitt Lymphoma (eBL) ...
Diseases, Conditions, Syndromes
Dec 11, 2012 |
3 / 5 (1) |
1
|
Weekly dose reduces targeted drug's side effects, but not its activity against ALL
A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ...
Cancer
Dec 11, 2012 |
not rated yet |
0
(Antibody) orientation matters
The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacter ...
Medical research
Dec 10, 2012 |
4 / 5 (1) |
0
Positive early results in clinical trial of leukaemia vaccine
Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.
Cancer
Dec 07, 2012 |
5 / 5 (1) |
0
Study shows antibody therapy clears Alzheimer's plaques in mice
Antibodies against amyloid beta (Aβ) protein deposits that are thought to play a role in Alzheimer's disease have shown some success in preventing the buildup of deposits in animals, but they have not been effective at removing ...
Alzheimer's disease & dementia
Dec 05, 2012 |
5 / 5 (5) |
0
|
Research shows immune system response is detrimental to novel brain cancer therapy
For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor. ...
Cancer
Dec 04, 2012 |
not rated yet |
0
Novel antibodies for combating Alzheimer's and Parkinson's disease
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, ...
Neuroscience
Dec 03, 2012 |
4 / 5 (2) |
1
|
